135 related articles for article (PubMed ID: 20022110)
1. Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes.
Matsuda A; Germing U; Jinnai I; Araseki K; Kuendgen A; Strupp C; Iwanaga M; Miyazaki Y; Hata T; Bessho M; Gattermann N; Tomonaga M
Leuk Res; 2010 Aug; 34(8):974-80. PubMed ID: 20022110
[TBL] [Abstract][Full Text] [Related]
2. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.
Matsuda A; Germing U; Jinnai I; Misumi M; Kuendgen A; Knipp S; Aivado M; Iwanaga M; Miyazaki Y; Tsushima H; Sakai M; Bessho M; Tomonaga M
Blood; 2005 Oct; 106(8):2633-40. PubMed ID: 15972453
[TBL] [Abstract][Full Text] [Related]
3. [Refractory anemia (RA) and refractory cytopenia with multilineage dysplasia (RCMD) in WHO classification: comparison between Japanese and German cases].
Matsuda A; Germing U
Rinsho Ketsueki; 2004 Apr; 45(4):268-73. PubMed ID: 15168441
[No Abstract] [Full Text] [Related]
4. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.
Cermák J; Michalová K; Brezinová J; Zemanová Z
Leuk Res; 2003 Mar; 27(3):221-9. PubMed ID: 12537974
[TBL] [Abstract][Full Text] [Related]
5. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
6. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
7. Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.
Matsuda A; Germing U; Jinnai I; Iwanaga M; Misumi M; Kuendgen A; Strupp C; Miyazaki Y; Tsushima H; Sakai M; Bessho M; Gattermann N; Aul C; Tomonaga M
Leukemia; 2007 Apr; 21(4):678-86. PubMed ID: 17268513
[TBL] [Abstract][Full Text] [Related]
8. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
9. [Myelodysplastic syndrome classification].
Ghariani I; Braham N; Hassine M; Kortas M
Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
11. Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.
Breccia M; Latagliata R; Cannella L; Carmosino I; Santopietro M; Loglisci G; Federico V; Alimena G
Leuk Lymphoma; 2010 May; 51(5):783-8. PubMed ID: 20302387
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of the WHO Classification De Novo Myelodysplastic Syndrome: Experience from Southern Pakistan.
Sultan S; Irfan SM; Jawed SN
Asian Pac J Cancer Prev; 2016; 17(3):1049-52. PubMed ID: 27039723
[TBL] [Abstract][Full Text] [Related]
13. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
14. Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification.
Matsuda A; Jinnai I; Iwanaga M; Okamura D; Ishikawa M; Maeda T; Hata T; Kawai N; Miyazaki Y; Bessho M; Tomonaga M
Am J Clin Pathol; 2013 Aug; 140(2):253-7. PubMed ID: 23897263
[TBL] [Abstract][Full Text] [Related]
15. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Font P; Loscertales J; Soto C; Ricard P; Novas CM; Martín-Clavero E; López-Rubio M; Garcia-Alonso L; Callejas M; Bermejo A; Benavente C; Ballesteros M; Cedena T; Calbacho M; Urbina R; Villarrubia J; Gil S; Bellón JM; Diez-Martin JL; Villegas A
Ann Hematol; 2015 Apr; 94(4):565-73. PubMed ID: 25387664
[TBL] [Abstract][Full Text] [Related]
16. Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts.
Maassen A; Strupp C; Giagounidis A; Kuendgen A; Nachtkamp K; Hildebrandt B; Gattermann N; Aul C; Haas R; Germing U
Leuk Res; 2013 Jan; 37(1):64-70. PubMed ID: 23122806
[TBL] [Abstract][Full Text] [Related]
17. Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes.
Breccia M; Carmosino I; Biondo F; Mancini M; Russo E; Latagliata R; Alimena G
Leuk Res; 2006 Feb; 30(2):178-82. PubMed ID: 16102825
[TBL] [Abstract][Full Text] [Related]
18. [Myelodysplastic syndromes--from FAB to WHO classification].
Kotlarek-Haus S; Haus O
Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
[No Abstract] [Full Text] [Related]
19. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.
Font P; Loscertales J; Benavente C; Bermejo A; Callejas M; Garcia-Alonso L; Garcia-Marcilla A; Gil S; Lopez-Rubio M; Martin E; Muñoz C; Ricard P; Soto C; Balsalobre P; Villegas A
Ann Hematol; 2013 Jan; 92(1):19-24. PubMed ID: 22948274
[TBL] [Abstract][Full Text] [Related]
20. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients.
Germing U; Gattermann N; Strupp C; Aivado M; Aul C
Leuk Res; 2000 Dec; 24(12):983-92. PubMed ID: 11077111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
